Sciact
  • EN
  • RU

Addition of HO-Acids to N ,N -Bis(oxy)enamines: Mechanism, Scope and Application to the Synthesis of Pharmaceuticals Full article

Journal European Journal of Organic Chemistry
ISSN: 1434-193X , E-ISSN: 1099-0690
Output data Year: 2017, Volume: 2017, Number: 41, Pages: 6209-6227 Pages count : 19 DOI: 10.1002/ejoc.201701266
Authors Naumovich Yana A. 1 , Golovanov Ivan S. 1 , Sukhorukov Alexey Yu. 1 , Ioffe Sema L. 1
Affiliations
1 Laboratory of Functional Organic Compounds, N. D. Zelinsky Institute of Organic Chemistry, Leninsky prospect, 47, 119991 Moscow, Russia

Abstract: The regioselectivity of the addition of HO-acids to the activated π bond in N,N-bis(oxy)enamines has been found to be dramatically dependent upon the solvent. Mechanistic investigations and quantum-chemical calculations revealed that solvent affects the reaction pathway. In basic solvents (DMF, NMP, DMSO), N,N-bis(oxy)enamines were converted into nitrosoalkenes by a Lewis base promoted process followed by oxy-Michael addition of the HO-acid. In non-polar solvents (toluene, CH2Cl2), the reaction occurs by an acid-promoted SN′ substitution of the N-oxy-group via a highly reactive N-vinyl-N-alkoxynitrenium species. Based on these studies, general and efficient protocols for the oximinoalkylation of various HO-acids (carboxylic acids, phenols, hydroxamic, phosphoric and sulfonic acids) employing readily available N,N-bis(oxy)enamines were developed. These methods proved to be applicable to the post-modification of natural molecules bearing acidic OH groups (such as steroidal hormones, bile acids, protected amino acids and peptides) and ligands (BINOL). The resulting α-oxyoximes were demonstrated to be useful precursors of valuable 1,2-amino alcohol or 1,2-hydroxylamino alcohol derivatives, including the antiarrhythmic drug Mexiletine and a potent matrix metalloproteinase inhibitor.
Cite: Naumovich Y.A. , Golovanov I.S. , Sukhorukov A.Y. , Ioffe S.L.
Addition of HO-Acids to N ,N -Bis(oxy)enamines: Mechanism, Scope and Application to the Synthesis of Pharmaceuticals
European Journal of Organic Chemistry. 2017. V.2017. N41. P.6209-6227. DOI: 10.1002/ejoc.201701266 WOS Scopus OpenAlex
Identifiers:
Web of science: WOS:000414849900014
Scopus: 2-s2.0-85033440907
OpenAlex: W2755939622
Citing:
DB Citing
OpenAlex 13
Web of science 15
Scopus 16
Altmetrics: